Verve Therapeutics, Inc.
SEC CIK 1840574 · VERV · last insider filing 2025-07-28
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Adelman Burt A | Director | filed 2021 - 2025 |
| Maclean Michael F | Director | filed 2021 - 2025 |
| Yeshwant Krishna | Director | filed 2021 - 2025 |
| Coats Lonnel | Director | filed 2022 - 2025 |
| Morrison Jodie Pope | Director | filed 2024 - 2025 |
| Cumbo Alexander | Director | filed 2022 - 2025 |
| Tatsis Ourania | Director | filed 2024 - 2025 |
| Kathiresan Sekar | Director · Chief Executive Officer | filed 2021 - 2025 |
| Mikhail Sheila | Director | filed 2021 - 2025 |
| Evans John M. | Director | filed 2021 - 2022 |
| Chen Bihua | Director | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Ashe Andrew D. | See Remarks | filed 2021 - 2025 |
| Dorval Allison | Chief Financial Officer | filed 2021 - 2025 |
| Nickerson Joan | Chief Administrative Officer | filed 2023 - 2025 |
| Lister Troy | Chief Scientific Officer | filed 2024 - 2025 |
| Politi Jason | Chief Technical Ops. Off. | filed 2024 - 2025 |
| Fiedorek Fred T. | Chief Medical Officer | filed 2023 - 2024 |
| Bellinger Andrew | Chief Scientific Officer | filed 2021 - 2024 |
| Beaudoin Margaret | Vice President, Finance | filed 2021 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.